Welsh Heart. Global Vision.

Gareth's Journey

From Rhymney's coal mines to Minnesota labs to Dallas' emerging life sciences hub, Gareth's fight with cancer reshaped Caizio's mission.

The Birth of an Entrepreneur

While researching DNA sensors and gene chips at the University of Minnesota, Gareth realized that he was built to fix things and thrived in the startup environment. In 1998, he joined his first medtech startup, MedCam, as their first full-time employee, developing miniature endoscopes.

Early research

Startup trajectory

Over the next two decades, Gareth launched five companies and guided dozens more. He saw firsthand the "Valley of Death", the gap between a brilliant scientific discovery in a lab and a viable product in a clinic. In 2012, he founded Caizio to serve as the bridge for this gap, creating a platform that integrated capital with technical studio support.

The Personal Battle

In 2019, the mission became personal. Gareth was diagnosed with Stage III Colon Cancer. He underwent surgery to remove half of his colon and endured six months of intensive chemotherapy.

Emerging from that experience cancer-free, Gareth’s vision for Caizio sharpened. It was no longer just about biomedical innovation; it was about an unwavering focus on oncology and hematology. He knew precisely what it felt like to be the patient at the end of the innovation chain.

Today, based in Dallas, Texas, and maintaining deep ties with his homeland through GlobalWelsh, Gareth leads Caizio with the resilience of the valleys and the precision of a PhD engineer.

Caizio operates as a tripartite mission, Support, Creation, and Investing, specifically designed to ensure that the next generation of diagnostics, medical devices, and immunotherapies don't just exist in a paper, but reach the patients who need them most.

Caizio Today